Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.
Also called NCT01888315
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 1,000 participants
- Registry
-
NCT01888315
-
- Other papers using this trial's data
- Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT01888315. Non-randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2021-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity
- Condition
- Hypertension
- Condition
- Heart Failure
- Condition
- Chronic Kidney Disease
- Condition
- Diabetes
- Condition
- Heart Rhythm Disorders
- Intervention (Device)
- Renal denervation with Symplicity Flex Medtronic/Ardian
- Intervention (Device)
- Renal denervation with EnligHTN St. Jude Medical
- Intervention (Device)
- Renal denervation with Paradise Recor
- Intervention (Device)
- Renal denervation with V2 Vessix
- Lead sponsor
- University Hospital, Saarland
Record details
- Record id
cardio:ct-nct01888315- Content hash
357039a3f1742aef42d4cc2665420f92d74df9cfa3913e549711268d594e54d2